More than 400 people attended UTMB’s Second Annual Clinical & Translational Research Forum, held Feb. 12 at Levin Hall. The Office of the Provost and the Institute for Translational Sciences sponsored the event which showcased the full spectrum of research at UTMB, as well as the resources provided by the institution’s core laboratories, centers and institutes.

Approximately 140 projects were featured, ranging from laboratory and animal experiments, to patient studies and clinical trials, to community and outcomes research. By sharing information and encouraging collaboration, the Forum supports translation of lab discoveries towards new diagnostics or treatments as well as the translation of feedback from patient populations and communities.

As a member of the national Clinical and Translational Science Award consortium, ITS is facilitating development of patient interventions, training a new generation of translational researchers, and engaging communities in research efforts. In doing so, the NIH-funded consortium is leveraging the rapidly increasing rate of scientific discovery to accelerate improvements in human health.

UTMB’s core laboratories, centers, and institutes play a key role by providing innovative technology and multidisciplinary expertise in such diverse areas as: advanced imaging, systems biology, visual analytics, and structural biology. These diverse resources make it possible for UTMB investigators to improve diagnosis and care for a variety of diseases and conditions. 

This year’s Forum featured scientific advances related to asthma, infectious disease, burn injury, aging, cancer, addiction, and obesity, among others.

For more information about the research and resources presented at the event, click here.